Up-to-the-minute newsfeed of the latest medical and scientific journal articles and abstracts related to pancreatic cancer.
The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs. Read more . . .
There is, however, a subset of patients who experience durable stable disease or partial responses after initial courses of chemotherapy Read more . . .
Indeed, immunotherapy has emerged in recent years as a potential adjunct treatment for solid tumors including PC. Immunotherapy modulates the host's immune response to tumor-associated antigens (TAAs), eradicates cancer cells…